Company Analysis CareRx Corporation
1. Summary
Advantages
- Price (1.96 $) is less than fair price (2 $)
- The stock's return over the last year (13.29%) is higher than the sector average (3.16%).
- Current debt level 36.97% is below 100% and has decreased over 5 years from 67.33%.
Disadvantages
- Dividends (0%) are below the sector average (2.17%).
- The company's current efficiency (ROE=-5.43%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CareRx Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -0.9% | 0.8% |
| 90 days | 1.6% | -2.8% | 7.2% |
| 1 year | 13.3% | 3.2% | 12.2% |
CHHHF vs Sector: CareRx Corporation has outperformed the "Healthcare" sector by 10.13% over the past year.
CHHHF vs Market: CareRx Corporation has outperformed the market by 1.1% over the past year.
Stable price: CHHHF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CHHHF with weekly volatility of 0.2557% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (1.96 $) is lower than the fair price (2 $).
Price not significantly lower than the fair price: The current price (1.96 $) is slightly lower than the fair price by 2%.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (59.99).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.44) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (1.44) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.3302) is lower than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (0.3302) is lower than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.14) is lower than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (8.14) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -15.05% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-15.05%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (-5.43%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (-5.43%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-1.98%) is lower than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (-1.98%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
